Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
08/02/2007 | US20070179110 Expression of immunogenic substances |
08/02/2007 | US20070179092 Method of Enhancing Neural Stem Cell Proliferation, Differentiation, and Survival Using Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) |
08/02/2007 | US20070179088 Foggy |
08/02/2007 | US20070178592 Lentiviral vectors featuring liver specific transcriptional enhancer and methods of using same |
08/02/2007 | US20070178591 Internally administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient |
08/02/2007 | US20070178590 Pluripotential embryonic stem cells and methods of making same |
08/02/2007 | US20070178589 Apparatus and method for culturing and preserving tissue constructs |
08/02/2007 | US20070178588 Tissue control rods for sheet-based tissue engineering |
08/02/2007 | US20070178587 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor |
08/02/2007 | US20070178586 Methods and apparatuses for growing cells |
08/02/2007 | US20070178585 Eukaryotic cell overexpressing an endogenous gene; introducing a vector containing a transcriptional regulatory sequence into the cell, allowing the vector to integrate into the genome of the cell by non-homologous recombination |
08/02/2007 | US20070178576 Purification of high-molecular compounds by means of affinity membrane chromatography |
08/02/2007 | US20070178562 Consensus/ancestral immunogens |
08/02/2007 | US20070178560 Measuring the energy transfer between fusion proteins comprising a leptin receptor and an energy donor protein ; bone disorders |
08/02/2007 | US20070178558 Cloning, sequencing and expression of a Comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli |
08/02/2007 | US20070178555 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
08/02/2007 | US20070178553 Mammalian T-type calcium channels |
08/02/2007 | US20070178552 Method for Making Multispecific Antibodies Having Heteromultimeric and Common Components |
08/02/2007 | US20070178551 Methods for producing modified glycoproteins |
08/02/2007 | US20070178544 Anti fk778antibodies and high sensitive immunoassay methods |
08/02/2007 | US20070178540 Goodpasture antigen binding protein |
08/02/2007 | US20070178539 Novel Cytokine Receptors and Nucleic Acids Encoding the Same |
08/02/2007 | US20070178535 Methods of identifying agents that modulate mitochondrial function |
08/02/2007 | US20070178532 Identification, quantification, and characterization of t cells and t cell antigens |
08/02/2007 | US20070178527 Human platelet-derived growth factor receptors |
08/02/2007 | US20070178522 Gold-binding protein and use thereof |
08/02/2007 | US20070178496 Thermus Thermophilus Nucleic Acid Polymerases |
08/02/2007 | US20070178492 Human tumor necrosis factor receptor polynucleotides |
08/02/2007 | US20070178489 Compositions and Methods for Enhanced Sensitivity and Specificity of Nucleic Acid Synthesis |
08/02/2007 | US20070178483 Novel cell-based assays for G-protein-coupled receptor-mediated activities |
08/02/2007 | US20070178469 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure fo mar sequences |
08/02/2007 | US20070178468 Multicellular organisms derived from normal/nondiseased and diseased mammalian tissues |
08/02/2007 | US20070178467 Gm1 promoter and use thereof |
08/02/2007 | US20070178462 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha1h, encoded proteins and methods of use thereof |
08/02/2007 | US20070178441 Method of Drug Interaction |
08/02/2007 | US20070178439 Control of es cell self renewal and lineage specification, and medium therefor |
08/02/2007 | US20070178435 Using nutrient broth comprising nanoparticle composed of hydrophobic core and lipophilic exterior as tool in preservation of mammalian heart ex vivo |
08/02/2007 | US20070178168 Comprises human erythrocytes and processed plasma to which D-dimer, and stabilizers, and optionally antimicrobial agents are added; monitoring a whole blood based D-dimer assay |
08/02/2007 | US20070178132 Injectable chondrocyte implant |
08/02/2007 | US20070178120 Virus-like particles as vaccines for paramyxovirus |
08/02/2007 | US20070178114 Novel kallikrein gene |
08/02/2007 | US20070178112 Immunoglobulins; immunogens |
08/02/2007 | US20070178109 glycoprotein 120; fusion proteins; myelin basic protein; autoimmune diseases; genetic vaccines |
08/02/2007 | US20070178106 Compositions and methods for enhancing nk cell activity |
08/02/2007 | US20070178105 FHIT proteins and nucleic acids and methods based thereon |
08/02/2007 | US20070178101 Ovr110 antibody compositions and methods of use |
08/02/2007 | US20070178100 genetically engineered T. cruzi wherein the amastigote stage-regulated protein is expressed from a gene involved in energy metabolism; suitable for use in diagnosis of Chagas disease, in drug development, in antibody production, and in the production of vaccines, including live vaccines |
08/02/2007 | US20070178097 Interleukin-10 antibodies |
08/02/2007 | US20070178088 Fibronectins; drug screening; treating cardiovascular/nervous system disorders |
08/02/2007 | US20070178086 Monoclonal antibody against ABCA1 |
08/02/2007 | US20070178077 Method for in vitro preconditioning of myoblasts before transplantation |
08/02/2007 | US20070178076 Porous membrane device that promotes the differentiation of monocytes into dendritic cells |
08/02/2007 | US20070178075 Side Population Cells in Cardiac Repair |
08/02/2007 | US20070178074 Chondrocyte Culture Formulations |
08/02/2007 | US20070178072 Method for inducing differentiation of regulatory t cells usinggip-anchored protein agonist and pharmaceutical composition therefor ( as amended |
08/02/2007 | US20070178064 Use to enhance apoptosis; antiproliferative agents; IAP (inhibitor-of apoptosis) |
08/02/2007 | DE10347436B4 In vitro Verfahren zur Diagnose der kardiovaskulären Funktionalität von Blut-abgeleiteter zirkulierender Vorläuferzellen (BDP) An in vitro method for diagnosing the cardiovascular functionality of blood-derived circulating precursor cells (BDP) |
08/02/2007 | DE102006003996A1 Method for the formation of heart muscle cells (cardiomyocytes), useful e.g. in medical application, comprises culturing and differentiating stem cells, which are obtained from differentiated exocrine gland tissue of an organism |
08/02/2007 | DE102006003854A1 Preparation of regulatory and cytotoxic CD8+ T cells, useful for treatment and prevention of immune reactions and associated disease, by treating naive cells with alpha-melanocyte-stimulating hormone |
08/02/2007 | CA2640116A1 Method op assessing the viability of thawed cells |
08/02/2007 | CA2639068A1 Method for culturing cells derived from the adipose tissue and uses thereof |
08/02/2007 | CA2637934A1 Human zip1, zinc and citrate for prostate cancer screening |
08/02/2007 | CA2637463A1 Synergistic compositions for treating hiv |
08/02/2007 | CA2636440A1 Method for producing autonomously contracting cardiac muscle cells from adult stem cells, in particular human adult stem cells |
08/02/2007 | CA2635915A1 Mesenchymal stem cells expressing tnf-.alpha. receptors |
08/02/2007 | CA2535127A1 H3 equine influenza a virus |
08/01/2007 | EP1813676A2 Retroviral vectors pseudotyped with influenza virus hemagglutin for gene delivery |
08/01/2007 | EP1813672A2 Transgenic non-human animals capable of producing heterologous antibodies |
08/01/2007 | EP1813671A1 Soluble protein and utilization of the same |
08/01/2007 | EP1813669A1 3-Phosphoglycerate dehydrogenase variants whose inhibition by L-serine is reduced, and genes encoding them |
08/01/2007 | EP1813668A1 Hybridoma capable of producing anti-dectin-1 monoclonal antibody |
08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
08/01/2007 | EP1813625A1 Method of modulating the profileration of medullary thyroid carcinoma cells |
08/01/2007 | EP1813624A1 Methods and compositions for the prevention and treatment of anemia |
08/01/2007 | EP1812602A2 Methods and kits for detecting mutations |
08/01/2007 | EP1812597A2 Mammalian genes involved in infection |
08/01/2007 | EP1812564A2 Defective influenza virus particles |
08/01/2007 | EP1812563A2 Methods of generating antigen-specific cd4+cd25+ regulatory t cells, compositions and methods of use |
08/01/2007 | EP1812562A1 Method for preparation of an autologous endometrial culture for an endometrium/embryo coculture |
08/01/2007 | EP1812561A2 Compositions, methods and systems for preparation of a stem cell-enriched cell population |
08/01/2007 | EP1812560A1 Retina-specific cells differentiated in vitro from bone marrow stem cells, the production thereof and their use |
08/01/2007 | EP1812559A1 A method for differentiation of pancreatic stem cells into insulin producing cells |
08/01/2007 | EP1812558A1 Identification and isolation of multipotent cells from non-osteochondral mesenchymal tissue |
08/01/2007 | EP1812557A2 Chemically defined media compositions |
08/01/2007 | EP1812556A2 Neuronal progenitors from feeder-free human embryonic stem cell culture |
08/01/2007 | EP1812555A2 Methods of expanding myeloid cell populations and uses thereof |
08/01/2007 | EP1812554A2 Derivation of embryonic stem cells |
08/01/2007 | EP1812549A1 A device comprising a sample of reconstructed tissue and a detection system |
08/01/2007 | EP1812465A1 Novel composition and methods for the treatment of immune related diseases |
08/01/2007 | EP1812463A2 Group 2 mite polypeptide variants |
08/01/2007 | EP1812459A1 Method for the mass production of multimeric mannose binding lectin |
08/01/2007 | EP1812458A2 Methods and compositions for seprase inactivation |
08/01/2007 | EP1812046A2 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
08/01/2007 | EP1812014A2 Compositions and methods for prolonging survival of platelets |
08/01/2007 | EP1811832A2 Ungulates with genetically modified immune systems |
08/01/2007 | EP1692272A4 Inhibition assay method and device for detection of antibiotics |
08/01/2007 | EP1581791A4 Method for measuring ion channel activity |
08/01/2007 | EP1572071A4 Systems and methods for treating patients with processed lipoaspirate cells |
08/01/2007 | EP1507561A4 Compositions for delivering nucleic acids to cells |
08/01/2007 | EP1470226B1 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide |